- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01833481
THA Kinematics and Sound for Subjects Implanted Using Various Surgical Approaches (THA)
In Vivo Determination of THA Kinematics and Sound for Subject Implanted Using Various Surgical Approaches
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Ontario
-
London, Ontario, Canada, N6A 5A5
- University Hospital
-
-
-
-
Maryland
-
Towson, Maryland, United States, 21201
- University of Maryland St. Joseph Medical Center
-
-
Washington
-
Renton, Washington, United States, 90855
- Valley Orthopedic Associates ASC
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Patients implanted with a direct-anterior surgical approach will be provided by Dr. William Barrett of Valley Orthopedic Associates in Renton, WA.
Patients implanted with an anterior-lateral surgical approach will be provided by Dr. of Steven J. MacDonald of the London Health Sciences Center, London, Ontario.
Patients implanted with a posterior-lateral approach will be provided by Dr. David F. Dalury of Towson Orthopaedic Associates, Inc. in Towson, MD.
Description
Inclusion Criteria:
- Post-operative clinical evaluation judged successful using Harris Hip Scoring (HHS) system (HHS>90)
- Body weight less than 270 lbs
- No evidence of post-operative hip subluxation or dislocation
- Do not walk with detectable limp
- Be able to actively abduct their operated hip against gravity without difficulty
- Must be willing to sign Informed Consent and Health Insurance Portability and Accountability (HIPAA) forms
Exclusion Criteria:
- Pregnant, lactating or females not using reliable form of birth control
- Patients that do not meet study requirements
- Patients unwilling to sign Informed Consent or HIPAA forms
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
THA using direct-anterior surgical approach
Patients will have undergone THA using a direct-anterior surgical approach and will undergo fluoroscopy surveillance while walking.
|
While each subject performs a gait activity (normal walking) under fluoroscopic surveillance on a level treadmill, a data acquisition (DAQ) system will be used to determine the vibrations/sounds occurring during walking.
Other Names:
|
THA using anterior-lateral approach
Patients will have undergone THA using an anterior-lateral surgical approach and will undergo fluoroscopy surveillance while walking.
|
While each subject performs a gait activity (normal walking) under fluoroscopic surveillance on a level treadmill, a data acquisition (DAQ) system will be used to determine the vibrations/sounds occurring during walking.
Other Names:
|
THA using posterior-lateral approach
Patients will have undergone THA using a posterior-lateral surgical approach and will undergo fluoroscopy surveillance while walking.
|
While each subject performs a gait activity (normal walking) under fluoroscopic surveillance on a level treadmill, a data acquisition (DAQ) system will be used to determine the vibrations/sounds occurring during walking.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Kinematics - Swing Phase Separation
Time Frame: 6 months post-operatively
|
Determine amount of in vivo swing phase hip separation present within implanted hip during weight-bearing level walking while under fluoroscopic surveillance.
|
6 months post-operatively
|
Kinematics - Stance Phase Separation
Time Frame: 6 months post-operative
|
Determine amount of stance phase hip separation present in vivo of implanted hip during level walking activity under fluoroscopic surveillance.
|
6 months post-operative
|
Kinematics - Overall Separation
Time Frame: 6 months post-operative
|
Determine overall hip separation present in vivo in implanted hip during level walking activity under fluoroscopic surveillance
|
6 months post-operative
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Adrija Sharma, Ph D, The University of Tennessee
- Principal Investigator: Richard D Komistek, Ph D, The University of Tennessee
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 12009
- R01 1373 452 (Other Identifier: University of Tennessee)
- 13-0372 (Other Identifier: University of Tennessee)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hip Injuries
-
Helse Stavanger HFRecruitingHip Fractures | Hip Injuries and DisordersNorway
-
FH ORTHORecruitingHip Fractures | Hip DiseaseFrance
-
Zhenjiang First People's HospitalCompletedHip Fractures | Hip DiseaseChina
-
Bayside HealthCompleted
-
University of LeedsCitieffe S.r.lUnknownUnilateral Unstable HipUnited Kingdom
-
Guy's and St Thomas' NHS Foundation TrustCompletedHip Fractures | Fracture of Hip | Fractured HipUnited Kingdom
-
Medipol UniversityWithdrawnHip Fractures | Hip Injuries | Hip ArthropathyTurkey
-
University Health Network, TorontoNot yet recruitingSurgery | Hip-fracture
-
Lund UniversityMalmo Municipality, SwedenRecruiting
Clinical Trials on Fluoroscopy surveillance of patients while walking
-
University Hospital, AngersRégion des Pays de la LoireCompletedPeripheral Artery DiseaseFrance
-
The University of Tennessee, KnoxvilleDePuy SynthesCompletedHip InjuriesUnited States
-
Kayseri City HospitalNot yet recruitingCoronary Artery Disease | ObesityTurkey
-
Maximilian DiehnAstraZenecaRecruitingNon Small Cell Lung Cancer | NSCLC, Stage III | NsclcUnited States